ARCHIVES

In Setback For Generics, Court Overturns FDA.

This article is from The Cancer Letter archive.

Vol. 27 No. 41 | November 9, 2001

Download PDF Visit The Full Archive

Related Articles

NCAB Gives President Evidence Supporting Limits On Tar, Nicotine

November 29, 1974

ORI Final Findings Of Scientific Misconduct

September 16, 1994

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

Majority of Invasive Bladder Cancer Patients Do Not Receive Full Recommended Care

August 26, 2011

Gerstner Resigns From NA, MSK Board After Taking RJR Job

March 24, 1989

Taking on question of cost and outcomes, CMS turns to expert in cancer care quality.

June 3, 2005